Cairo – Mubasher: Ibnsina Pharma on Sunday reported a 31.6% year-on-year increase in profits for the first nine months of 2018.
The company logged EGP 188.3 million in the nine-month period ended September, versus EGP 143.1 million in the prior-year period, according to a filing to the Egyptian Exchange (EGX).
Ibnsina Pharma previously posted a net profit EGP 75.18 million for the first half of 2018, versus EGP 53.66 million in H1-17.
